APA

Laursen S. B., Leontiadis G. I., Stanley A. J., Hallas J. & Schaffalitzky de Muckadell O. B. (20171211). The use of selective serotonin receptor inhibitors (SSRIs) is not associated with increased risk of endoscopy-refractory bleeding, rebleeding or mortality in peptic ulcer bleeding. : Alimentary pharmacology & therapeutics.

Chicago

Laursen S B, Leontiadis G I, Stanley A J, Hallas J and Schaffalitzky de Muckadell O B. 20171211. The use of selective serotonin receptor inhibitors (SSRIs) is not associated with increased risk of endoscopy-refractory bleeding, rebleeding or mortality in peptic ulcer bleeding. : Alimentary pharmacology & therapeutics.

Harvard

Laursen S. B., Leontiadis G. I., Stanley A. J., Hallas J. and Schaffalitzky de Muckadell O. B. (20171211). The use of selective serotonin receptor inhibitors (SSRIs) is not associated with increased risk of endoscopy-refractory bleeding, rebleeding or mortality in peptic ulcer bleeding. : Alimentary pharmacology & therapeutics.

MLA

Laursen S B, Leontiadis G I, Stanley A J, Hallas J and Schaffalitzky de Muckadell O B. The use of selective serotonin receptor inhibitors (SSRIs) is not associated with increased risk of endoscopy-refractory bleeding, rebleeding or mortality in peptic ulcer bleeding. : Alimentary pharmacology & therapeutics. 20171211.